Convergent Evolution of Antibiotic Resistance Mechanisms Between Pyrrolobenzodiazepines and Albicidin in Multidrug Resistant Klebsiella Pneumoniae
5 Articles
5 Articles
Convergent evolution of antibiotic resistance mechanisms between pyrrolobenzodiazepines and albicidin in multidrug resistant Klebsiella pneumoniae
Pyrrolobenzodiazepines (PBDs) containing C8-linked aliphatic heterocycles have been developed as a new class of potent antibacterial compounds. They are active against multidrug resistant Gram-negative pathogens, including Klebsiella pneumoniae. When isolates were exposed to PBDs, they acquired resistance, with significant increases in inhibitory concentrations. Resistant strains showed mutations in genes associated with resistance to albicidin,…
The First in 30 Years: Scientists Discover New Class of Antibiotics
Researchers have found a powerful new antibiotic candidate, lariocidin, that could combat drug-resistant bacteria and transform the fight against antimicrobial resistance. It has been nearly thirty years since a new class of antibiotics reached the market, but that could soon change. Researchers at McMaster University have made a breakthrough that could help turn the tide [...]
Autoimmune diseases affect between 5 and 10% of the world’s population, according to the Global Autoimmune Institute. It is a set of conditions in which the immune system mistakenly attacks the body itself, causing from chronic inflammations to severe organic damage. Among the most well-known are multiple sclerosis, lupus, type 1 diabetes, rheumatoid arthritis and celiac disease. Until now, traditional treatments seek to suppress the immune syst…
Coverage Details
Bias Distribution
- 67% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage